Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenu ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

By now, many have seen the commercials with NBA legend Kareem Abdul-Jabbar explaining the importance of seeing ...

A research team at Haeundae Sharing and Happiness Hospital, a local hospital in Busan, published its study on the ...

Triple T offers a faster, safer alternative to surgery, by selectively destroying the small adrenal nodule without removing the adrenal gland.

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

The following is a summary of “Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid ...

Until now, the only effective cure for primary aldosteronism has been surgical removal of the entire adrenal gland, requiring ...